Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens

Area of Science:

• Microbiology
• Vaccinology
• Infectious Diseases

Background:

• Global rise in multidrug-resistant (MDR) ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species) poses a significant healthcare challenge.
• These pathogens exhibit resistance to multiple antibiotic classes, leading to treatment failures, increased morbidity, mortality, and healthcare costs.
• Existing infection control measures are strained by the escalating threat of antimicrobial resistance.

Purpose of the Study:

• To review advancements in target-driven vaccine research against MDR ESKAPE pathogens.
• To identify promising vaccine targets, including conserved surface antigens, iron acquisition systems, and biofilm-related proteins.
• To explore novel vaccine platforms for developing next-generation formulations.

Main Methods:

• Genomic discovery of highly conserved surface antigens and other potential targets.
• Computational prediction of epitopes for broad-spectrum vaccination.
• Evaluation of novel vaccine platforms like outer membrane vesicles (OMVs), mRNA technologies, and multi-epitope constructs.

Main Results:

• Identification of conserved antigens, iron acquisition systems, and biofilm/quorum-sensing proteins as attractive vaccine targets.
• Emergence of advanced vaccine platforms (OMVs, mRNA, multi-epitope) poised for rapid translation.
• Recognition of ongoing challenges including antigenic variation and immune evasion.

Conclusions:

• Development of effective vaccines against MDR ESKAPE pathogens requires continued interdisciplinary research and investment.
• Addressing challenges like immune evasion and ensuring robust mucosal immunity are critical for vaccine success.
• Successful vaccines are essential to mitigate the global burden of antimicrobial resistance.